In the present study, we demonstrated that miR-137 decreased the migration/invasion of MDA-MB-231 partly through ERRα-WNT11 pathway, providing an alternative way to inhibit the migration of cancer cells with high migratory capacity. Here, ESRRA is linked to cancer.